Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Dr Colvin stated in his oral evidence "if you had abandoned all surgery except for the most life-saving and the home treatment programme and if you had cut back on dosage...the consequences of the temporary withdrawal of all blood products in the way that Dr Galbraith perfectly understandably recommended was a probable."
Published on:
30 September, 2024
Dr Colvin reported that there were 41 patients infected with HIV, of which 31 had severe Haemophilia A, 9 had moderate/mild Haemophilia A and 1 had Haemophilia B. He recalled three children who were infected with HIV from their treatment and one partner of a patient who was infected.
Published on:
30 September, 2024
Dr Craske explained that there was a "possibility" that transmission by blood and blood products may become "a serious problem" and that in the UK "widespread transmission could occur...unless precautions are taken to exclude donors from the already identified high risk group for AIDS".
Published on:
30 September, 2024
Dr Craske reported to the UKHCDO on the cases of AIDS in different parts of the world given. The number of cases in patients with hereditary disorders of blood coagulation had reached 21 in the USA. 7 cases in Europe had been reported, including two in the UK. Description of a recent study of 7 patients with AIDS associated with blood transfusion.
Published on:
30 September, 2024
Minutes from the meeting of UK Haemophilia Centre Directors where Professor Bloom stated the the UK was recognised throughout the world as having the best organisation for treatment of haemophilic patients and Dr Craske asked for special attention to be given to his report on HTLV III the importance of accurate incidence of HIV in the UK and a need for better reporting
Published on:
30 September, 2024
Appendix collated by Dr Craske containing graphs and histograms based on reports received by Haemophilia Centres on patients who received the same batches of blood products as the Cardiff and Bristol AIDS cases.
Published on:
30 September, 2024
Inquiry publishes expert report on Public Health and Administration
Published on:
13 September, 2022
Dr Lane in a letter to the reference centre directors stated that it was agreed that a meeting should be held "to discuss AIDS in relation to the management of haemophiliacs and the implications for treatment with factor VIII concentrates" and that 10 December was the first date suitable for the majority of participants.
Published on:
30 September, 2024
In a response to Dr Lane, Professor Bloom wrote that "clearly the matter is of great importance and has certainly come to a head with the Australian experience and with the unfortunate death of the Newcastle patient. I am only glad that we had decided in advance of these events to take some action"
Published on:
30 September, 2024
In a letter to Dr Lane, Dr Rizza suggested a number of questions which he thought needed to be considered at the meeting, including whether directors should now switch to using only heat-treated Factor 8 concentrates.
Published on:
30 September, 2024
Dr Lane produced an agenda for the meeting with the Haemophilia Centre Directors.
Published on:
30 September, 2024
In the US over 6,000 cases of AIDS were reported including 52 people with haemophilia and 102 cases in the UK with 3 reported in people with haemophilia.
Published on:
30 September, 2024
Professor Bloom wrote to Dr Ludlam seeking comments on his draft notes of Reference Centre Directors meeting on 14 December 1984.
Published on:
30 September, 2024
Professor Bloom wrote to Dr Lane seeking comments on his draft notes of Reference Centre Directors meeting on 14 December 1984.
Published on:
30 September, 2024
UKHCDO's AIDS Group was told that the Haemophilia Reference Centre AIDS Advisory Document dated 14 December 1984 was sent to all haemophilia centres in the UK.
Published on:
30 September, 2024
UKHCDO's AIDS Group heard a difference of opinion with regard to Factor 9. "Some Centres had stopped using NHS factor IX and were now using heated commercial factor IX while others intended to continue for the meantime with the unheated NHS factor IX."
Published on:
30 September, 2024
Annual return for 1983 shows Frimley Park Haemophilia Centre treated 4 Haemophilia A patients and 1 von Willebrand's disease patient that year.
Published on:
30 September, 2024
Dr Dempsey stated that there was "resistance among the haemophilia treaters about the significance of concentrate and the emerging AIDS problem."
Published on:
30 September, 2024
Dr Dempsey commented that he had "no major doubt" or "no real doubt" that AIDS was transmissible by blood or blood products "because any alternative theory didn't really seem to hold water"
Published on:
30 September, 2024
Dr Dempsey mentioned that the best decision would have been to go onto NHS material, as opposed to cryoprecipitate in the 1980s.
Published on:
30 September, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2313
Page
2314
Page
2315
Page
2316
Current page
2317
Page
2318
Page
2319
Page
2320
Page
2321
…
Next page
Next
Last page
Last